Clearmind Medicine Inc. (CMND) vs Propanc Biopharma, Inc. (PPCB)
A side-by-side comparison of Clearmind Medicine Inc. and Propanc Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CMND
Clearmind Medicine Inc.
$5.70HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
PPCB
Propanc Biopharma, Inc.
$0.52HealthcareDelayed quote: Oct 6, 2026, 12:12 PM EDT
Total return — CMND vs PPCB
growth of $100 · dividends reinvested · last 3yCMND -99.6% (-84.3%/yr)PPCB +0.0% (+0.0%/yr)PPCB compounded faster over this window
Log scale — wide-divergence pair
CMND PPCB
CMND vs PPCB: by the numbers
- •PPCB is the larger company ($1M vs $1M market cap).
Metrics side by side
Valuation
| Metric | CMND | PPCB |
|---|---|---|
| P/B ratio | 0.08 | 0.13 |
Profitability
| Metric | CMND | PPCB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -57.87% | -200.63% |
| ROIC | -60.41% | -183.49% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.